Chris Myer - INVO Old Sr Americas
| INVODelisted Stock | USD 0.72 0.02 2.70% |
Insider
Chris Myer is Sr Americas of INVO Old
| Phone | 978 878 9505 |
| Web | https://www.invobioscience.com |
INVO Old Management Efficiency
The company has return on total asset (ROA) of (0.2657) % which means that it has lost $0.2657 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (143.5864) %, meaning that it created substantial loss on money invested by shareholders. INVO Old's management efficiency ratios could be used to measure how well INVO Old manages its routine affairs as well as how well it operates its assets and liabilities.INVO Old currently holds 8.68 M in liabilities with Debt to Equity (D/E) ratio of 0.6, which is about average as compared to similar companies. INVO Old has a current ratio of 1.95, which is within standard range for the sector. Note, when we think about INVO Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Xiao Yang | CLPS Inc | 60 | |
| Peter Facchini | Enveric Biosciences | 61 | |
| MBA IV | Enveric Biosciences | 68 | |
| Srustijeet Mishra | CLPS Inc | N/A | |
| Sharon Keys | NLS Pharmaceutics AG | N/A | |
| Joseph Tucker | Enveric Biosciences | 56 | |
| John MD | Lixte Biotechnology Holdings | 87 | |
| Chad MBA | NLS Pharmaceutics AG | N/A | |
| Wilson Wong | CLPS Inc | N/A | |
| Ibrahim MD | Enveric Biosciences | 55 | |
| Miranda MBA | Entera Bio | 48 | |
| Rui Yang | CLPS Inc | 42 | |
| Avani Kanubaddi | Enveric Biosciences | 51 | |
| Ming Lin | CLPS Inc | 61 | |
| iur LLM | NLS Pharmaceutics AG | 58 | |
| James MD | Lixte Biotechnology Holdings | 77 | |
| Rhon Galicha | CLPS Inc | N/A | |
| Robert Weingarten | Lixte Biotechnology Holdings | 73 | |
| II MD | Entera Bio | 71 | |
| Eric JD | Lixte Biotechnology Holdings | 46 | |
| Hillel MBA | Entera Bio | 47 | |
Management Performance
| Return On Equity | -143.59 | |||
| Return On Asset | -0.27 |
INVO Old Leadership Team
Elected by the shareholders, the INVO Old's board of directors comprises two types of representatives: INVO Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of INVO. The board's role is to monitor INVO Old's management team and ensure that shareholders' interests are well served. INVO Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, INVO Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin MD, Medical Director | ||
| FACS FACOG, VP Integration | ||
| Bojan Mitrovic, Director US | ||
| Lori MarzilliKahler, VP Operations | ||
| Michael Campbell, COO Development | ||
| Terah Krigsvold, Controller | ||
| Chris Myer, Sr Americas | ||
| Steven Shum, CEO Director | ||
| Andrea Goren, Chief Officer | ||
| Robert Bowdring, Treasurer Secretary |
INVO Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is INVO Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -143.59 | |||
| Return On Asset | -0.27 | |||
| Profit Margin | (1.23) % | |||
| Operating Margin | (1.04) % | |||
| Current Valuation | 15.19 M | |||
| Shares Outstanding | 3.91 M | |||
| Shares Owned By Insiders | 0.60 % | |||
| Shares Owned By Institutions | 3.00 % | |||
| Number Of Shares Shorted | 1.95 K | |||
| Price To Book | 5.97 X |
Pair Trading with INVO Old
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if INVO Old position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INVO Old will appreciate offsetting losses from the drop in the long position's value.Moving against INVO Stock
| 0.49 | DPSTF | Deutsche Post AG | PairCorr |
| 0.48 | KO | Coca Cola Earnings Call This Week | PairCorr |
| 0.45 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
| 0.39 | VWAGY | Volkswagen AG 110 | PairCorr |
| 0.38 | VLKAF | Volkswagen AG | PairCorr |
The ability to find closely correlated positions to INVO Old could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace INVO Old when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back INVO Old - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling INVO Old to buy it.
The correlation of INVO Old is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as INVO Old moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if INVO Old moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for INVO Old can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in INVO Stock
If you are still planning to invest in INVO Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the INVO Old's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |